ArticleAnnals of surgical oncology2026
Multifactorial Impact of Age, Race, and Female Sex on Management of Non-small Cell Lung Cancer.
Article in Annals of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundThe purpose of this study was to evaluate the impact of age and race on female patients with non-small cell lung cancer (NSCLC) and identify factors posing a greater risk to overall survival (OS). PATIENTS AND
methodsA retrospective analysis of the Southern Community Cohort Study database was conducted of female patients diagnosed with NSCLC from 2004 to 2018. Patients were stratified into Black versus white groups and by age: < 55 years and ≥ 55 years. Fisher's exact test was used to compare categorical variables and Wilcoxon rank sum for numerical variables. Hazard ratios were calculated to assess risk on OS for both races.
resultsBlack female patients, more often than white female patients, were diagnosed with pathologic stage IV (43.2% versus 33.9%, p = 0.02), did not receive lymphadenectomy (75.3% versus 64.8%, p = 0.02), and did not undergo surgery of the primary site (80.2% versus 65.4%, p = 0.002). Age-stratified analysis revealed more apparent trends for Black female patients. Compared with their older counterparts, younger Black female patients presented with larger tumor sizes (43.7 mm versus 40.2 mm), were more often diagnosed with clinical metastasis (11.6% versus 8.8%), and had higher rates of death due to their malignancy (74.0% versus 58.1%). Factors protective for OS were private insurance (HR 0.51 Black versus HR 0.34 white), number of persons in household (HR 0.78 Black versus HR 0.80 white). Urban environment was protective for Black female patients (HR 0.75) and rural environment for white female patients (HR 0.60).
conclusionsDisparities are prevalent in different groups of female patients with NSCLC. Continued work is imperative to improve care for this increasingly vulnerable demographic.
Indexed as
Identifiers
41832358What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.